Track the 에이프릴바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 에이프릴바이오 has recorded 46 public disclosures. Market capitalisation: €421.6bn. The latest transaction was filed on 1 July 2026 (Sale). Among the most active insiders: 유한양행. Every trade is accessible without an account.
40
Insider Decl.
n/a
Thresholds
n/a
20 ops.
Buy Volume
n/a
13 ops.
Sell Volume
Fundamental score
Ranked 18,055 of 29,065 companies
44.5
score / 100
Value
30
Quality
59
FCF yld-0.9%
Earn yld-2.3%
EV/EBITDA·
ROE-11%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
April Bio is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.